NCT01440023

Brief Summary

Many researchers suspect that individuals with Tourette Syndrome (TS) may have a poor cognitive ability (i.e., response inhibition; RI) that is essential to inhibit inappropriate response such as vocal or motor tics. The investigators aim to test whether a well-established behavior therapy for TS can be improved by increasing the individual's RI capabilities. To this end, 20 children will be randomly assigned to behavior therapy with computer-based RI training or behavior therapy with placebo computer-based cognitive training. The investigators will test the hypothesis that computer-based RI training can be a useful addition to the well-established behavior therapy to enhance its therapeutic effect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Aug 2011

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 2, 2011

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 23, 2011

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 15, 2015

Status Verified

January 1, 2015

Enrollment Period

3.3 years

First QC Date

September 2, 2011

Last Update Submit

January 13, 2015

Conditions

Keywords

tic disordertourette syndromehabit reversalresponse inhibitioncognitive retraining

Outcome Measures

Primary Outcomes (1)

  • Change in scores on the Yale Global Tic Severity Scale (YGTSS) across baseline, 4-week, 8-week, and 12 week assessments. during and after the treatment from baseline

    The YGTSS is a well-validated instrument that produces severity ratings for motor and vocal tics, impairment caused by the tics, and an overall severity score of tic symptoms.

    At baseline, 4 week (mid-treatment), 8 week (post-treatment), and 12 week (1-month follow-up)

Secondary Outcomes (1)

  • Change in scores on the Clinical Global Impression Severity and Improvement (CGI-S and CGI-I) across baseline, 4-week, 8-week, and 12 week assessments.

    At baseline, 4 week (mid-treatment), 8 week (post-treatment), and 12 week (1-month follow-up)

Study Arms (2)

CBIT + Response Inhibition Training

EXPERIMENTAL

CBIT is an 8 session treatment protocol held over 10 weeks. In CBIT, core components are implemented across the various therapy sessions. These core components include habit reversal training (HRT), functional assessment/function-based interventions, and a behavioral reward program for the child. Each core component is briefly described below. HRT/CBIT involves three components, awareness training, competing response training, and social support training (Woods, Twohig, Roloff, \& Flessner, 2003). For this condition, CBIT will be combined with adjunctive computerized response inhibition training, which will be delivered over the first 4 weeks of the CBIT treatment.

Behavioral: Comprehensive Behavioral Intervention for Tics (CBIT)Behavioral: Computerized Response Inhibition Training

Experimental: CBIT + Placebo Computer Training

PLACEBO COMPARATOR

In this condition, participants receive the same package of CBIT treatment, which consists of awareness training, competing response training, and social support training (Woods, Twohig, Roloff, \& Flessner, 2003). Additionally, the standard CBIT treatment is combined with computer-based placebo cognitive training that is irrelevant to the target cognitive ability (i.e., response inhibition). During the first 4 weeks of the CBIT treatment, participants will receive 8 sessions of placebo cognitive training.

Behavioral: Comprehensive Behavioral Intervention for Tics (CBIT)Behavioral: Computerized Placebo Cognitive Training

Interventions

CBIT is an 8 session treatment protocol held over 10 weeks. Its core components are implemented across the various therapy sessions. These core components include habit reversal training (HRT), functional assessment/function-based interventions, and a behavioral reward program for the child.

Also known as: Habit Reversal for Tourette Syndrome
CBIT + Response Inhibition TrainingExperimental: CBIT + Placebo Computer Training

Twice-weekly 45 minute computerized sessions for cognitive training focused on enhancing response inhibition capabilities.

CBIT + Response Inhibition Training

Twice-weekly 45 minute computerized sessions for placebo cognitive training, which has been designed to be irrelevant for response inhibition capabilities.

Experimental: CBIT + Placebo Computer Training

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • age between 9 and 17
  • a diagnosis of TS or chronic tic disorder on the structured diagnostic interview
  • moderate to severe levels of tic symptoms (YGTSS total score \> 13 for TS, or \> 9 for CTD), and (d) IQ \> 80.

You may not qualify if:

  • current substance abuse or dependence
  • current or past psychotic disorder, bipolar disorder, or schizophrenia
  • or more previous sessions of behavioral treatments for tic
  • significant suicidal ideation and/or attempts within the past 3 months
  • any recent (in the previous month) or planned change in medication for tic symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Psychology Clinic, University of Wisconsin-Milwaukee

Milwaukee, Wisconsin, 53211, United States

Location

MeSH Terms

Conditions

Tourette SyndromeTic Disorders

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Han Joo Lee, Ph.D.

    University of Wisconsin, Milwaukee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Psychology

Study Record Dates

First Submitted

September 2, 2011

First Posted

September 23, 2011

Study Start

August 1, 2011

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 15, 2015

Record last verified: 2015-01

Locations